Research map: Profitability Of Infused Biologics For Hospitals And Physician Practices: Case Study Of Keytruda

Back to the article

Papers in this map

  1. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance · James C. Robinson · 2024 · 31 citations · Cited by this paper
  2. The Extent Of Gender/Sex Variables Included In Clinical Algorithms Across Medical Specialties · 2026 · Related
  3. The unintended consequences of the 340B safety‐net drug discount program · Samuel Thomas · 2020 · 18 citations · Cited by this paper
  4. Participatory Systems Science To Identify Local Adaptation Strategies For Extreme Heat In King County, Washington · 2026 · Related
  5. Price Differences To Insurers For Infused Cancer Drugs In Hospital Outpatient Departments And Physician Offices · James C. Robinson · 2021 · 18 citations · Cited by this paper
  6. Health Insurance As Climate Adaptation: A Practical Framework · 2026 · Related
  7. Hospital Adoption and Pricing for Oncology Biosimilars · James C. Robinson · 2026 · 7 citations · Cited by this paper
  8. The Uneven Distribution Of Patient Portal Messages Across Patients And Physicians · 2026 · Related
  9. The Association of 340B Program Drug Margins with Covered Entity Characteristics · Robert J. Nordyke · 2025 · 2 citations · Cited by this paper
  10. Who Pays When Temperatures Soar? · 2026 · Related
  11. Errata · 2026 · Related
  12. Rhode Island’s Affordability Standards Led To Substantial Reductions In Hospital Staffing And Labor Costs By 2022 · 2026 · Related
  13. Cold-Related Illness In An Era Of Extreme Climate Events: US Trends, 1998–2022 · 2026 · Related
  14. Health Care Workers In A Storm’s Path · 2026 · Related
  15. The South Had The Lowest Rates Of Hospice And Palliative Medicine–Certified Providers In The US, 2024 · 2026 · Related

Source: OpenAlex (CC0)